PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
02-Feb-2021 RauCon Guarantees Business Development Event Planning Dependability RauCon
02-Feb-2021 Recipharm and Medspray Launch Resyca Joint Venture to Exploit Novel Softmist Technology for Pharmaceutical Applications Recipharm and Medspray
02-Feb-2021 ONTOZRYTM (cenobamate) receives positive CHMP opinion for the adjunctive treatment of uncontrolled focal onset seizures in adults* Arvelle Therapeutics
02-Feb-2021 Novartis receives positive CHMP opinion for Kesimpta® (ofatumumab), a self-administered treatment for adult patients with relapsing multiple sclerosis with active disease Novartis
02-Feb-2021 Bayer receives approval in the UK for Xarelto® (rivaroxaban) to treat children with venous thromboembolism (VTE) and to prevent VTE recurrence Bayer
02-Feb-2021 Albumedix enters into collaboration agreement with Cell and Gene Therapy Catapult Albumedix Ltd.
02-Feb-2021 Scenic Biotech Appoints Dr. Philippe Dro as Independent Chairman B3C newswire
02-Feb-2021 Harbour BioMed and ProBioGen Agree on a GlymaxX® License to Fast-Track Cell Line Development Projects B3C newswire
01-Feb-2021 Fresenius Medical Care AG & Co. KGaA anticipates significant negative impact on 2021 net income from accelerated COVID-19 related excess mortality of dialysis patients; confirms mid-term targets Fresenius Medical Care AG & Co. KGaA
01-Feb-2021 Fresenius SE & Co. KGaA: Excess mortality of dialysis patients impacts Group net income in FY/21 Fresenius SE & Co. KGaA
01-Feb-2021 Fresenius Medical Care AG & Co. KGaA anticipates significant negative impact on 2021 net income due to accelerated impact of Covid-19 related excess mortality on its patient population Fresenius Medical Care AG & Co. KGaA
01-Feb-2021 Recipharm and Medspray Launch Resyca Joint Venture to Exploit Novel Softmist Technology for Pharmaceutical Applications B3C newswire
01-Feb-2021 Sepha Launches Small Batch Contract Packaging Service Sepha
01-Feb-2021 HAEMATO AG: Patrick Brenske to be the sole member of the Executive Board of HAEMATO AG in the future HAEMATO AG
01-Feb-2021 Chiesi Group receives the European Marketing authorisation for Trimbow® (beclometasone dipropionate, formoterol fumarate, glycopyrronium) an extrafine formulation fixed triple combination therapy for the treatment of asthma Chiesi Group
01-Feb-2021 Immudex launches dCODE Dextramer® (RiO), a new reagent compatible with BD Rhapsodyâ„¢ Single Cell Analysis system Immudex
01-Feb-2021 Evotec CSO Cord Dohrmann Appointed to German Council of Science and Humanities Evotec SE
29-Jan-2021 Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Announces Nominations to Reappoint Ulrich Dauer as CEO and to Appoint Florian Schmid as CFO Vivoryon Therapeutics N.V.
29-Jan-2021 Cherwell Publishes a Growth Promotion Testing Guide Cherwell Laboratories
29-Jan-2021 CROMSOURCE Consolidates Strategic Site Support Service CROMSOURCE